inzolfi
sandoz d.d. - fingolimodas - kietosios kapsulės - 0,5 mg - fingolimod
fingolimod mylan
mylan ireland limited - fingolimod hidrochloridas - išsėtinė sklerozė, grįžtamoji-pervedimo - imunosupresantai - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older:patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 ir 5. 1)orpatients su sparčiai besivystančiomis sunkus grįžtamoji pervedimo išsėtinės sklerozės apibrėžta 2 ar daugiau išjungus atkryčių po metų, ir su 1 ar daugiau gadolinio didinti pakitimų smegenų mrt arba gerokai padidinti t2 pralaimėjimai apkrovos, palyginti su ankstesniais neseniai mrt.
vumerity
biogen netherlands b.v. - diroximel fumarate (biib098) - išsėtinė sklerozė, grįžtamoji-pervedimo - imunosupresantai - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).
fingolimod mylan
mylan ireland limited - fingolimod hidrochloridas - išsėtinė sklerozė, grįžtamoji-pervedimo - imunosupresantai - indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult and paediatric patients aged 10 years and older: patients with highly active disease despite a full and adequate course of treatment with at least one disease modifying therapy (for exceptions and information about washout periods see sections 4. 4 ir 5. 1) or patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.
fingolimod richter
gedeon richter plc - fingolimodas - kietosios kapsulės - 0,5 mg - fingolimod
dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetilfumaratas - išsėtinė sklerozė, grįžtamoji-pervedimo - imunosupresantai - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
fingolimod stada
stada arzneimittel ag - fingolimodas - kietosios kapsulės - 0,5 mg - fingolimod
inzolfi
sandoz d.d. - fingolimodas - kietosios kapsulės - 0,25 mg - fingolimod
dimtruzic
sandoz d.d. - dimetilfumaratas - skrandyje neirios kietosios kapsulės - 120 mg - dimethyl fumarate
dimtruzic
sandoz d.d. - dimetilfumaratas - skrandyje neirios kietosios kapsulės - 240 mg - dimethyl fumarate